Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability-Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study

Authors
Category Primary study
Conference2024 International Congress of Parkinson's Disease and Movement Disorders
Year 2024
This article has no abstract
Epistemonikos ID: 38c863bfa6cc72e0e89e0aeea54ec222a849d606
First added on: Jan 10, 2026